Targeting hydrogen sulfide as a promising therapeutic strategy for atherosclerosis

International Journal of Cardiology

Volumn 172, Issue 2, 2014, Pages 313-317

  Xu, Suowen ^a,b   Liu, Zhiping ^a   Liu, Peiqing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Atherosclerosis; Cystathionine lyase; Gasotransmitter; Hydrogen sulfide

Indexed keywords

ACS 14; ACS 15; ANTIINFLAMMATORY AGENT; CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; GYY 4137; HYDROGEN SULFIDE; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; S PROPARGYLCYSTEINE; SALICYLIC ACID DERIVATIVE; SODIUM HYDROSULFIDE; UNCLASSIFIED DRUG; CARBON DIOXIDE; MORPHOLINE DERIVATIVE; PHOSPHOROTHIOIC ACID DERIVATIVE;

ATHEROGENESIS; ATHEROSCLEROSIS; BIOGENESIS; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MECHANISM; GARLIC; GENE SILENCING; HEART PROTECTION; HUMAN; IN VIVO STUDY; MOLECULAR PATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; ANIMAL; DEFICIENCY; METABOLISM; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ATHEROSCLEROSIS; CARBON DIOXIDE; CYSTATHIONINE GAMMA-LYASE; HUMANS; HYDROGEN SULFIDE; MICE; MORPHOLINES; NITRIC OXIDE; ORGANOTHIOPHOSPHORUS COMPOUNDS; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 84900582665     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.01.068     Document Type: Review

References (50)

1. P. Libby Mechanisms of acute coronary syndromes and their implications for therapy N Engl J Med 368 2013 2004 2013
2. S. Xu, P. Bai, P.J. Little, and P. Liu Poly(ADP-ribose) Polymerase-1 (PARP1) in atherosclerosis: from molecular mechanisms to therapeutic implications Med Res Rev 2013 10.1002/med.21300
3. J. Ferrieres Effects on coronary atherosclerosis by targeting low-density lipoprotein cholesterol with statins Am J Cardiovasc Drugs 9 2009 109 115
4. L. Rochette, Y. Cottin, M. Zeller, and C. Vergely Carbon monoxide: mechanisms of action and potential clinical implications Pharmacol Ther 137 2013 133 152
5. I. Ohsawa, M. Ishikawa, and K. Takahashi et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals Nat Med 13 2007 688 694
6. I. Ohsawa, K. Nishimaki, K. Yamagata, M. Ishikawa, and S. Ohta Consumption of hydrogen water prevents atherosclerosis in apolipoprotein E knockout mice Biochem Biophys Res Commun 377 2008 1195 1198
7. C. Szabo Hydrogen sulphide and its therapeutic potential Nat Rev Drug Discov 6 2007 917 935
8. G. Yang, L. Wu, and B. Jiang et al. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase Science 322 2008 587 590
9. R. Wang Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter? FASEB J 16 2002 1792 1798
10. S. Mani, A. Untereiner, L. Wu, and R. Wang Hydrogen sulfide and the pathogenesis of atherosclerosis Antioxid Redox Signal 20 2014 805 817
11. R. Wang Physiological implications of hydrogen sulfide: a whiff exploration that blossomed Physiol Rev 92 2012 791 896
12. Y. Wang, X. Zhao, and H. Jin et al. Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice Arterioscler Thromb Vasc Biol 29 2009 173 179
13. D.J. Lefer A new gaseous signaling molecule emerges: cardioprotective role of hydrogen sulfide Proc Natl Acad Sci U S A 104 2007 17907 17908
14. W. Qiao, T. Chaoshu, J. Hongfang, and D. Junbao Endogenous hydrogen sulfide is involved in the pathogenesis of atherosclerosis Biochem Biophys Res Commun 396 2010 182 186
15. R. Wang Shared signaling pathways among gasotransmitters Proc Natl Acad Sci U S A 109 2012 8801 8802
16. C. Coletta, A. Papapetropoulos, and K. Erdelyi et al. Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation Proc Natl Acad Sci U S A 109 2012 9161 9166
17. G. Yang, K. Zhao, and Y. Ju et al. Hydrogen sulfide protects against cellular senescence via S-sulfhydration of Keap1 and activation of Nrf2 Antioxid Redox Signal 18 2013 1906 1919
18. Q.H. Meng, G. Yang, W. Yang, B. Jiang, L. Wu, and R. Wang Protective effect of hydrogen sulfide on balloon injury-induced neointima hyperplasia in rat carotid arteries Am J Pathol 170 2007 1406 1414
19. H. Zhang, C. Guo, and D. Wu et al. Hydrogen sulfide inhibits the development of atherosclerosis with suppressing CX3CR1 and CX3CL1 expression PLoS One 7 2012 e41147
20. H. Laggner, M.K. Muellner, and S. Schreier et al. Hydrogen sulphide: a novel physiological inhibitor of LDL atherogenic modification by HOCl Free Radic Res 41 2007 741 747
21. L.L. Pan, X.H. Liu, Q.H. Gong, D. Wu, and Y.Z. Zhu Hydrogen sulfide attenuated tumor necrosis factor-alpha-induced inflammatory signaling and dysfunction in vascular endothelial cells PLoS One 6 2011 e19766
22. E.G. Lynn, and R.C. Austin Hydrogen sulfide in the pathogenesis of atherosclerosis and its therapeutic potential Expert Rev Clin Pharmacol 4 2011 97 108
23. L. Li, M. Whiteman, and Y.Y. Guan et al. Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide Circulation 117 2008 2351 2360
24. G. Yang, H. Li, and G. Tang et al. Increased neointimal formation in cystathionine gamma-lyase deficient mice: role of hydrogen sulfide in alpha5beta1-integrin and matrix metalloproteinase-2 expression in smooth muscle cells J Mol Cell Cardiol 52 2012 677 688
25. G. Yang, L. Wu, and R. Wang Pro-apoptotic effect of endogenous H2S on human aorta smooth muscle cells FASEB J 20 2006 553 555
26. Z.Z. Zhao, Z. Wang, and G.H. Li et al. Hydrogen sulfide inhibits macrophage-derived foam cell formation Exp Biol Med 236 2011 169 176
27. X.H. Wang, F. Wang, and S.J. You et al. Dysregulation of cystathionine gamma-lyase (CSE)/hydrogen sulfide pathway contributes to ox-LDL-induced inflammation in macrophage Cell Signal 25 2013 2255 2262
28. M. Whiteman, L. Li, P. Rose, C.H. Tan, D.B. Parkinson, and P.K. Moore The effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of inflammatory mediators in macrophages Antioxid Redox Signal 12 2010 1147 1154
29. S.Y. Wu, C.S. Pan, and B. Geng et al. Hydrogen sulfide ameliorates vascular calcification induced by vitamin D3 plus nicotine in rats Acta Pharmacol Sin 27 2006 299 306
30. G. Zagli, R. Patacchini, and M. Trevisani et al. Hydrogen sulfide inhibits human platelet aggregation Eur J Pharmacol 559 2007 65 68
31. E. Grambow, F. Mueller-Graf, E. Delyagina, M. Frank, A. Kuhla, and B. Vollmar Effect of the hydrogen sulfide donor GYY4137 on platelet activation and microvascular thrombus formation in mice Platelets 2013 10.3109/09537104.2013. 786823
32. Z.F. Chen, B. Zhao, and X.Y. Tang et al. Hydrogen sulfide regulates vascular endoplasmic reticulum stress in apolipoprotein E knockout mice Chin Med J (Engl) 124 2011 3460 3467
33. L. Li, P. Rose, and P.K. Moore Hydrogen sulfide and cell signaling Annu Rev Pharmacol Toxicol 51 2011 169 187
34. L.L. Pan, X.H. Liu, Q.H. Gong, H.B. Yang, and Y.Z. Zhu Role of cystathionine gamma-lyase/hydrogen sulfide pathway in cardiovascular disease: a novel therapeutic strategy? Antioxid Redox Signal 17 2012 106 118
35. A. Martelli, L. Testai, and M.C. Breschi et al. Hydrogen sulphide: novel opportunity for drug discovery Med Res Rev 32 2012 1093 1130
36. H. Wang, X. Jiang, and F. Yang et al. Hyperhomocysteinemia accelerates atherosclerosis in cystathionine beta-synthase and apolipoprotein E double knock-out mice with and without dietary perturbation Blood 101 2003 3901 3907
37. S. Mani, G. Yang, and R. Wang A critical life-supporting role for cystathionine gamma-lyase in the absence of dietary cysteine supply Free Radic Biol Med 50 2011 1280 1287
38. S. Mani, H. Li, and A. Untereiner et al. Decreased endogenous production of hydrogen sulfide accelerates atherosclerosis Circulation 127 2013 2523 2534
39. D. Li, and J.L. Mehta Oxidized LDL, a critical factor in atherogenesis Cardiovasc Res 68 2005 353 354
40. G.A. Benavides, G.L. Squadrito, and R.W. Mills et al. Hydrogen sulfide mediates the vasoactivity of garlic Proc Natl Acad Sci U S A 104 2007 17977 17982
41. Y.P. Lei, H.W. Chen, L.Y. Sheen, and C.K. Lii Diallyl disulfide and diallyl trisulfide suppress oxidized LDL-induced vascular cell adhesion molecule and E-selectin expression through protein kinase A- and B-dependent signaling pathways J Nutr 138 2008 996 1003
42. Y.P. Lei, C.T. Liu, L.Y. Sheen, H.W. Chen, and C.K. Lii Diallyl disulfide and diallyl trisulfide protect endothelial nitric oxide synthase against damage by oxidized low-density lipoprotein Mol Nutr Food Res 54 Suppl. 1 2010 S42 S52
43. W. Guo, Z.Y. Cheng, and Y.Z. Zhu Hydrogen sulfide and translational medicine Acta Pharmacol Sin 34 2013 1284 1291
44. L.L. Pan, X.H. Liu, H.M. Zheng, H.B. Yang, Q.H. Gong, and Y.Z. Zhu S-propargyl-cysteine, a novel hydrogen sulfide-modulated agent, attenuated tumor necrosis factor-alpha-induced inflammatory signaling and dysfunction in endothelial cells Int J Cardiol 155 2012 327 332
45. X. Fu, K. Zhou, and Q. Gao et al. 17beta-Estradiol attenuates atherosclerosis development: the possible role of hydrogen sulfide Int J Cardiol 167 2013 1061 1063
46. M. Whiteman, and P.G. Winyard Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising Expert Rev Clin Pharmacol 4 2011 13 32
47. H. Zhang, C. Guo, and A. Zhang et al. Effect of S-aspirin, a novel hydrogen-sulfide-releasing aspirin (ACS14), on atherosclerosis in apoE-deficient mice Eur J Pharmacol 697 2012 106 116
48. R. Baskar, A. Sparatore, P. Del Soldato, and P.K. Moore Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative inhibit rat vascular smooth muscle cell proliferation Eur J Pharmacol 594 2008 1 8
49. Z. Liu, Y. Han, and L. Li et al. The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E(-/-) mice Br J Pharmacol 169 2013 1795 1809
50. X. Liao, J.C. Sluimer, and Y. Wang et al. Macrophage autophagy plays a protective role in advanced atherosclerosis Cell Metab 15 2012 545 553